[Observational retrospective study to evaluate the effectiveness and safety of treatment schemes with bortezomib for multiple myeloma in our hospital].

Author: Iranzo FernándezM D, León-VillarJ, Moreno BelmonteM J, Titos-ArcosJ C, de Arriba de la FuenteF

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To analyse therapeutic regimens including bortezomib used in our centre for the treatment of multiple myeloma, to evaluate its effectiveness and safety in clinical practice in our hospital, and to assess the appropriateness of the indications described in guidelines. MATERIAL AND METHOD...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.farma.2011.06.019

データ提供:米国国立医学図書館(NLM)

Bortezomib: A Promising Treatment for Multiple Myeloma

Multiple myeloma, a complex and often challenging cancer, can be likened to a shifting sand dune – constantly evolving and requiring innovative treatment strategies. This research examines the effectiveness and safety of bortezomib, a powerful drug used in the treatment of multiple myeloma. The study explores the clinical use of bortezomib in a real-world setting, analyzing its impact on patient outcomes.

Bortezomib Shows Positive Results in Multiple Myeloma Treatment

The study observed high overall response rates for patients treated with regimens incorporating bortezomib, both in first-line and salvage treatment settings. The response rates observed in this study are comparable to those reported in previous research, further highlighting the potential of bortezomib as a valuable treatment option for multiple myeloma. While the overall response to bortezomib is promising, the study also recognizes the need for further research to better understand the optimal conditions for its use in clinical practice.

Navigating the Side Effects of Bortezomib

Like navigating a treacherous desert, treating multiple myeloma requires a careful balance. This study highlights the importance of considering the potential side effects of bortezomib, including neurotoxicity and gastrointestinal toxicity. While the effectiveness of bortezomib is undeniable, it is essential to weigh its benefits against its potential risks. This research underscores the need for a personalized approach, considering individual patient factors and potential side effects.

Dr. Camel's Conclusion

This study provides a comprehensive overview of the role of bortezomib in the treatment of multiple myeloma, revealing its effectiveness and highlighting the importance of careful patient monitoring. While bortezomib offers a valuable tool in the fight against this challenging disease, it is crucial to remain vigilant about potential side effects and to continue exploring the optimal conditions for its use in clinical practice.
Date :
  1. Date Completed 2013-01-17
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

22115856

DOI: Digital Object Identifier

10.1016/j.farma.2011.06.019

Related Literature

SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.